UBS Group’s PHI, Inc. PHII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,678
| Closed | -$4K | – | 8662 |
|
|
2018
Q4 | $4K | Sell |
1,678
-7,179
| -81% | -$45.1K | ﹤0.01% | 7696 |
|
|
2018
Q3 | $79K | Buy |
8,857
+1,140
| +15% | +$10.3K | ﹤0.01% | 5787 |
|
|
2018
Q2 | $81K | Sell |
7,717
-1,238
| -14% | -$14.9K | ﹤0.01% | 5606 |
|
|
2018
Q1 | $92K | Buy |
8,955
+31
| +0.3% | +$359 | ﹤0.01% | 5274 |
|
|
2017
Q4 | $104K | Buy |
8,924
+294
| +3% | +$3.47K | ﹤0.01% | 5327 |
|
|
2017
Q3 | $102K | Buy |
8,630
+57
| +0.7% | +$612 | ﹤0.01% | 5311 |
|
|
2017
Q2 | $85K | Buy |
8,573
+539
| +7% | +$5.7K | ﹤0.01% | 5279 |
|
|
2017
Q1 | $94K | Sell |
8,034
-23
| -0.3% | -$342 | ﹤0.01% | 5112 |
|
|
2016
Q4 | $144K | Sell |
8,057
-810
| -9% | -$13.3K | ﹤0.01% | 5023 |
|
|
2016
Q3 | $163K | Sell |
8,867
-1,355
| -13% | -$25.6K | ﹤0.01% | 4683 |
|
|
2016
Q2 | $170K | Sell |
10,222
-118
| -1% | -$2.23K | ﹤0.01% | 4650 |
|
|
2016
Q1 | $196K | Sell |
10,340
-6,602
| -39% | -$117K | ﹤0.01% | 4505 |
|
|
2015
Q4 | $301K | Sell |
16,942
-56
| -0.3% | -$1.11K | ﹤0.01% | 4347 |
|
|
2015
Q3 | $333K | Buy |
16,998
+25
| +0.1% | +$671 | ﹤0.01% | 4219 |
|
|
2015
Q2 | $557K | Sell |
16,973
-68
| -0.4% | -$2.17K | ﹤0.01% | 4029 |
|
|
2015
Q1 | $511K | Sell |
17,041
-279
| -2% | -$9.4K | ﹤0.01% | 4123 |
|
|
2014
Q4 | $623K | Buy |
+17,320
| New | +$690K | ﹤0.01% | 3993 |
|
UBS Group's PHII Position: Q1 2019 in Review
UBS Group sold out of PHI, Inc. (PHII) in Q1 2019, closing a stake of 1,678 shares — an estimated $4K sold.
UBS Group first reported a position in PHII in Q4 2014 and held it in 17 quarters. The position peaked at $623K in Q4 2014. 0 funds tracked by Wall St. Rank hold PHII as of Q1 2019.
- UBS Group reported no remaining PHI, Inc. position as of Q1 2019 after selling out during the quarter.
- UBS Group sold 1,678 PHI, Inc. shares in Q1 2019, an estimated $4K.
- UBS Group first reported a position in PHI, Inc. in Q4 2014 and held it in 17 quarters.
- UBS Group's PHI, Inc. position peaked at $623K in Q4 2014.
- 0 funds tracked by Wall St. Rank held PHI, Inc. as of Q1 2019.
Based on UBS Group's 13F filing for Q1 2019, filed 14 May 2019.